Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ-95566692 |
| Trade Name | |
| Synonyms | JNJ95566692|JNJ 95566692 |
| Drug Descriptions |
Limited information is currently available on JNJ-95566692, a putative trispecific antibody targeting CD79b, MS4A1 (CD20), and CD3 (Feb 2026). |
| DrugClasses | CD20 Antibody 28 CD3 Antibody 123 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JNJ-87801493 + JNJ-95566692 | JNJ-87801493 JNJ-95566692 | 0 | 1 |
| JNJ-95566692 | JNJ-95566692 | 0 | 0 |